Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000107 · ClinicalTrials.gov registry record
Body Water Content in Cyanotic Congenital Heart Disease
A clinical trial, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
NCT00000107: Completed study, sponsored by National Center for Research Resources (NCRR).
NCT00000107 is a clinical trial that has completed, run by National Center for Research Resources (NCRR). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000107 has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
Study Summary
Adults with cyanotic congenital heart disease have elevated levels of plasma proatrial natruretic peptide (proANP) which most likely results in chronic dehydration, leading to reduced oxygen transport to tissues and shortness of breath with activity. The purpose of this study is to characterize adults with cyanotic congenital heart defects with respect to their body composition (water and fat-free mass) and resting metabolic rates. The study consists of several measures of how much body water, fat and lean tissue a subject has, and measures the number of calories the subject's body uses at rest. Adult subjects with cyanotic congenital heart disease will be recruited along with healthy noncyanotic control subjects matched for age, gender, and body weight.
Trial Details
| Field | Value |
|---|
What the finished NCT00000107 record still lists
NCT00000107 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 0 interventions.
NCT00000107 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000107 about?
NCT00000107 is a clinical study titled "Body Water Content in Cyanotic Congenital Heart Disease". Adults with cyanotic congenital heart disease have elevated levels of plasma proatrial natruretic peptide (proANP) which most likely results in chronic dehydration, leading to reduced oxygen transport to tissues and shortness of breath with activity. The purpose of this study is to characterize adul...
What is the current status of trial NCT00000107?
This trial is currently completed.
Who is sponsoring clinical trial NCT00000107?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.